Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Sarcoma 1Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Postoperative Period × 1 year × Clear all
NCT01709292 2026-04-16

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
24 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT07422974 2026-02-20

Neocolon

Osijek University Hospital

Recruiting
68 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07298070 2026-01-02

REFEPLI

Hôpital NOVO

Not yet recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT03896620 2025-12-24

Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma

Medical College of Wisconsin

Recruiting
50 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡